Altimmune, Inc. (ALT) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $41.0K | +105.0% |
| 2024 | $20.0K | -95.3% |
| 2023 | $426.0K | +726.5% |
| 2022 | -$68.0K | -101.5% |
| 2021 | $4.41M | — |
| 2011 | $24.27M | +15.6% |
| 2010 | $20.99M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $41.0K | +105.0% |
| 2024 | $20.0K | -95.3% |
| 2023 | $426.0K | +726.5% |
| 2022 | -$68.0K | -101.5% |
| 2021 | $4.41M | — |
| 2011 | $24.27M | +15.6% |
| 2010 | $20.99M | — |